Cornerstone Research always puts out great data and this report on Securities Class Action Filings for the first half of 2018 is no exception. I recommend you check out the full report which you can find here. These visuals really speak for themselves but the big takeaway is that if you are publicly traded company … Continue reading Why Securities Class Filings are a Reality for Publicly Traded Companies
Tag: Biotech
Friday Morning’s Top Articles
Happy Friday! Here is what I am reading as we head into the weekend: Talk about hitting on a lot of points, super insightful article - Regeneron’s Billionaire Founder Battles The Drug Pricing System (Forbes). Bio Roundup: An Alzheimer’s Head-Scratcher, OUTBio, GSK & Gilead Shakeups (Xconomy) When healthcare devices go over the counter. An important … Continue reading Friday Morning’s Top Articles
Monday Morning Healthcare News
It's a new week and this is what I'm reading to get going: While Tech Waffles On Going Public, Biotech IPOs Boom (Crunchbase) Smart Bandage Can Dispense Drugs, While Keeping An Eye On Your Wound (FORBES) Tendyne investors sue Abbott over $50m milestone (MassDevice). In case you missed, my thoughts on how a company can … Continue reading Monday Morning Healthcare News
MattCorc 